2.7% Below Target

The consensus price target for CPT is $111.89, close to the current price of $108.99 (2.7% implied move). Based on 41 analyst estimates, the stock appears fairly valued near current levels.

CPT has a consensus rating of "Hold" based on 41 Wall Street analysts. The rating breakdown is mixed, with 20 Hold ratings making up the largest segment. The consensus 12-month price target of $111.89 implies 2.7% upside from current levels.

At a forward P/E of 66.5588x, CPT trades at a premium valuation. The consensus price target of $111.89 (2.7% upside) suggests analysts may view current valuations as stretched.

The most bullish Wall Street analyst has a price target of $123 for CPT, while the most conservative target is $102. The consensus of $111.89 represents the median expectation. Our quantitative valuation model projects a bull case target of $128 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CPT is heavily covered by Wall Street, with 41 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 18 have Buy ratings, 20 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CPT stock forecast based on 41 Wall Street analysts shows a consensus price target of $111.89, with estimates ranging from $102 (bear case) to $123 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $97, with bear/bull scenarios of $61/$128.

Our quantitative valuation model calculates CPT's fair value at $97 (base case), with a bear case of $61 and bull case of $128. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 54/100.

CPT trades at a forward P/E ratio of 66.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 30.8x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

CPT appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $111.89 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CPT analyst price targets range from $102 to $123, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $111.89 consensus represents the middle ground. Our model's $61-$128 range provides an independent fundamental perspective.